Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE)’s stock price gapped up prior to trading on Friday . The stock had previously closed at $0.78, but opened at $0.74. Ampio Pharmaceuticals shares last traded at $0.73, with a volume of 60,457 shares changing hands.
Separately, Roth Capital initiated coverage on shares of Ampio Pharmaceuticals in a research note on Thursday, December 19th. They issued a “buy” rating and a $4.00 target price for the company.
Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) last issued its quarterly earnings data on Thursday, November 7th. The specialty pharmaceutical company reported ($0.05) earnings per share (EPS) for the quarter.
About Ampio Pharmaceuticals (NYSEAMERICAN:AMPE)
Ampio Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds. Its product pipeline includes Ampion, an intra-articular injection for the treatment of osteoarthritis of the knee.
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.